Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 403

1.

Impact of chlorination on silver elution from ceramic water filters.

Lyon-Marion BA, Mittelman AM, Rayner J, Lantagne DS, Pennell KD.

Water Res. 2018 Oct 1;142:471-479. doi: 10.1016/j.watres.2018.06.008. Epub 2018 Jun 5.

PMID:
29920457
2.

Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer.

Bednarczyk RB, Tuli NY, Hanly EK, Rahoma GB, Maniyar R, Mittelman A, Geliebter J, Tiwari RK.

Oncotarget. 2018 Mar 23;9(36):24272-24282. doi: 10.18632/oncotarget.24917. eCollection 2018 May 11.

3.

Comment on "A re-assessment of the safety of silver in household water treatment: rapid systematic review of mammalian in vivo genotoxicity studies".

Lantagne D, Rayner J, Mittelman A, Pennell K.

Environ Health. 2017 Nov 13;16(1):121. doi: 10.1186/s12940-017-0334-1.

4.

Accuracy, precision, usability, and cost of portable silver test methods for ceramic filter factories.

Meade RD, Murray AL, Mittelman AM, Rayner J, Lantagne DS.

J Water Health. 2017 Feb;15(1):72-82. doi: 10.2166/wh.2016.156.

PMID:
28151441
5.

Neurocognitive function in paediatric obsessive-compulsive disorder.

Geller DA, Abramovitch A, Mittelman A, Stark A, Ramsey K, Cooperman A, Baer L, Stewart SE.

World J Biol Psychiatry. 2018 Mar;19(2):142-151. doi: 10.1080/15622975.2017.1282173. Epub 2017 Feb 14.

6.

Aqueous Aggregation Behavior of Engineered Superparamagnetic Iron Oxide Nanoparticles: Effects of Oxidative Surface Aging.

Li W, Lee SS, Mittelman AM, Liu D, Wu J, Hinton CH, Abriola LM, Pennell KD, Fortner JD.

Environ Sci Technol. 2016 Dec 6;50(23):12789-12798. Epub 2016 Nov 16.

PMID:
27934273
7.

NEUROPSYCHOLOGICAL PREDICTORS OF TREATMENT RESPONSE TO COGNITIVE BEHAVIORAL GROUP THERAPY IN OBSESSIVE-COMPULSIVE DISORDER.

Braga DT, Abramovitch A, Fontenelle LF, Ferrão YA, Gomes JB, Vivan AS, Ecker KK, Bortoncello CF, Mittelman A, Miguel EC, Trentini CM, Cordioli AV.

Depress Anxiety. 2016 Sep;33(9):848-61. doi: 10.1002/da.22509. Epub 2016 Apr 21.

PMID:
27100799
8.

Silver Dissolution and Release from Ceramic Water Filters.

Mittelman AM, Lantagne DS, Rayner J, Pennell KD.

Environ Sci Technol. 2015 Jul 21;49(14):8515-22. doi: 10.1021/acs.est.5b01428. Epub 2015 Jun 26.

PMID:
26068303
9.

Comorbidity Between Attention Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder Across the Lifespan: A Systematic and Critical Review.

Abramovitch A, Dar R, Mittelman A, Wilhelm S.

Harv Rev Psychiatry. 2015 Jul-Aug;23(4):245-62. doi: 10.1097/HRP.0000000000000050. Review.

10.

Neuropsychological investigations in obsessive-compulsive disorder: A systematic review of methodological challenges.

Abramovitch A, Mittelman A, Tankersley AP, Abramowitz JS, Schweiger A.

Psychiatry Res. 2015 Jul 30;228(1):112-20. doi: 10.1016/j.psychres.2015.04.025. Epub 2015 Apr 30. Review.

PMID:
25957648
11.

Research Review: Neuropsychological test performance in pediatric obsessive-compulsive disorder--a meta-analysis.

Abramovitch A, Abramowitz JS, Mittelman A, Stark A, Ramsey K, Geller DA.

J Child Psychol Psychiatry. 2015 Aug;56(8):837-47. doi: 10.1111/jcpp.12414. Epub 2015 Apr 13.

PMID:
25866081
12.

The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.

Sulkowski ML, Geller DA, Lewin AB, Murphy TK, Mittelman A, Brown A, Storch EA.

Curr Psychiatry Rev. 2014;10(4):317-324.

13.

The neuropsychology of adult obsessive-compulsive disorder: a meta-analysis.

Abramovitch A, Abramowitz JS, Mittelman A.

Clin Psychol Rev. 2013 Dec;33(8):1163-71. doi: 10.1016/j.cpr.2013.09.004. Epub 2013 Sep 29.

PMID:
24128603
14.

Mathematical modeling of the transport and dissolution of citrate-stabilized silver nanoparticles in porous media.

Taghavy A, Mittelman A, Wang Y, Pennell KD, Abriola LM.

Environ Sci Technol. 2013 Aug 6;47(15):8499-507. doi: 10.1021/es400692r. Epub 2013 Jul 19.

PMID:
23819811
15.

Getting to the heart of influenza.

Yewdell JW, Spiro DJ, Golding H, Quill H, Mittelman A, Nabel GJ.

Sci Transl Med. 2013 Jun 26;5(191):191ed8. doi: 10.1126/scitranslmed.3006735. No abstract available.

16.

Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

McGuire JF, Lewin AB, Geller DA, Brown A, Ramsey K, Mutch J, Mittelman A, Micco J, Jordan C, Wilhelm S, Murphy TK, Small BJ, Storch EA.

Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38.

17.

Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants.

Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK.

PLoS One. 2012;7(2):e30839. doi: 10.1371/journal.pone.0030839. Epub 2012 Feb 20.

18.

Endothelial progenitor cell biology in disease and tissue regeneration.

George AL, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK.

J Hematol Oncol. 2011 May 24;4:24. doi: 10.1186/1756-8722-4-24. Review.

19.

Identification of PSA peptide mimotopes using phage display peptide library.

Shanmugam A, Suriano R, Chaudhuri D, Rajoria S, George A, Mittelman A, Tiwari RK.

Peptides. 2011 Jun;32(6):1097-102. doi: 10.1016/j.peptides.2011.04.018. Epub 2011 Apr 22.

PMID:
21539876
20.

Identification of peptide mimotopes of gp96 using single-chain antibody library.

Shanmugam A, Suriano R, Goswami N, Chaudhuri D, Ashok BT, Rajoria S, George AL, Mittelman A, Tiwari RK.

Cell Stress Chaperones. 2011 Mar;16(2):225-34. doi: 10.1007/s12192-010-0234-6. Epub 2010 Oct 16.

21.

Sialic acid content of tissue-specific gp96 and its potential role in modulating gp96-macrophage interactions.

Suriano R, Ghosh SK, Chaudhuri D, Mittelman A, Banerjee A, Tiwari RK.

Glycobiology. 2009 Dec;19(12):1427-35. doi: 10.1093/glycob/cwp096. Epub 2009 Jul 3.

PMID:
19578160
22.

Targeting the immune system in cancer.

Chaudhuri D, Suriano R, Mittelman A, Tiwari RK.

Curr Pharm Biotechnol. 2009 Feb;10(2):166-84. Review.

PMID:
19199949
23.

Degenerate binding of tyrosinase peptides to MHC II Ad/Ed molecules.

Mittelman A, Lucchese G, Stufano A, Kanduc D.

J Exp Ther Oncol. 2007;6(3):231-9.

PMID:
17552363
24.

Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis.

Polimeno L, Mittelman A, Gennero L, Ponzetto A, Lucchese G, Stufano A, Kusalik A, Kanduc D.

Amino Acids. 2008 Apr;34(3):479-84. Epub 2007 Apr 26.

PMID:
17458624
25.

Non-redundant peptidomes from DAPs: towards "the vaccine"?

Kanduc D, Lucchese A, Mittelman A.

Autoimmun Rev. 2007 Apr;6(5):290-4. Epub 2006 Oct 12. Review.

PMID:
17412300
26.

aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: coordinate involvement of the regions including BCR and ABL.

Bartos JD, Gaile DP, McQuaid DE, Conroy JM, Darbary H, Nowak NJ, Block A, Petrelli NJ, Mittelman A, Stoler DL, Anderson GR.

Mutat Res. 2007 Feb 3;615(1-2):1-11. Epub 2007 Jan 2.

27.

Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report.

Angelini G, Bonamonte D, Lucchese A, Favia G, Serpico R, Mittelman A, Simone S, Sinha AA, Kanduc D.

J Transl Med. 2006 Oct 24;4:43.

28.

Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous.

Lucchese A, Mittelman A, Tessitore L, Serpico R, Sinha AA, Kanduc D.

J Transl Med. 2006 Aug 22;4:37.

29.

Gene therapy in cancer: the missing point.

Kanduc D, Geliebter J, Lucchese A, Mazzanti R, Mittelman A, Polimeno L, Ponzetto A, Santacroce R, Simone S, Sinigaglia E, Sinha AA, Tessitore L, Tiwari RK, Farber E.

J Exp Ther Oncol. 2005;5(2):151-8. Review.

PMID:
16471041
30.

Characterization of polyclonal antibodies raised against a linear peptide determinant of desmoglein-3.

Angelini G, Bonamonte D, Lin MS, Lucchese A, Mittelman A, Serpico R, Simone S, Sinha AA, Kanduc D.

J Exp Ther Oncol. 2005;5(1):1-7.

PMID:
16416595
31.

3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer.

Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK.

Biochem Biophys Res Commun. 2006 Feb 10;340(2):718-25. Epub 2005 Dec 20.

PMID:
16380095
32.

Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer.

Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK.

Prostate. 2006 Apr 1;66(5):453-62.

PMID:
16353249
33.

Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinity.

Lucchese A, Willers J, Mittelman A, Kanduc D, Dummer R.

J Immunol. 2005 Nov 15;175(10):7009-20.

34.

Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention.

Suriano R, Ghosh SK, Ashok BT, Mittelman A, Chen Y, Banerjee A, Tiwari RK.

Cancer Res. 2005 Jul 15;65(14):6466-75.

35.

Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.

Willers J, Lucchese A, Mittelman A, Dummer R, Kanduc D.

Exp Dermatol. 2005 Jul;14(7):543-50.

PMID:
15946243
36.
37.

Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10.

Lucchese A, Mittelman A, Lin MS, Kanduc D, Sinha AA.

J Transl Med. 2004 Dec 11;2(1):43.

38.

Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.

Garikapaty VP, Ashok BT, Chen YG, Mittelman A, Iatropoulos M, Tiwari RK.

Oncol Rep. 2005 Jan;13(1):89-93.

PMID:
15583807
39.

Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity.

Tiwari R, Geliebter J, Lucchese A, Mittelman A, Kanduc D.

Peptides. 2004 Nov;25(11):1865-71.

PMID:
15501517
40.

Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis.

Reyes I, Reyes N, Iatropoulos M, Mittelman A, Geliebter J.

Prostate. 2005 May 1;63(2):169-86.

PMID:
15486989
41.

Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining.

Mittelman A, Tiwari R, Lucchese G, Willers J, Dummer R, Kanduc D.

J Invest Dermatol. 2004 Oct;123(4):670-5.

42.
43.

NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope.

Kanduc D, Fanizzi FP, Lucchese G, Stevanovic S, Sinha AA, Mittelman A.

Peptides. 2004 Feb;25(2):243-50.

PMID:
15063005
44.

Induction of heat shock protein gp96 by immune cytokines.

Chen YG, Ashok BT, Liu X, Garikapaty VP, Mittelman A, Tiwari RK.

Cell Stress Chaperones. 2003 Fall;8(3):242-8.

45.

Cancer prevention and therapy: strategies and problems.

Kanduc D, Capuano F, Capurso SA, Geliebter J, Guercia D, Lucchese A, Mittelman A, Simone SM, Sinha AA, Tiwari R, Farber E.

J Exp Ther Oncol. 2003 May-Jun;3(3):108-14. Review.

PMID:
14641817
46.

Molecular phenotyping of the immune system by microarray analysis.

Geliebter J, Mittelman A, Tiwari RK.

Cancer Invest. 2003 Apr;21(2):293-303. Review. No abstract available.

PMID:
12743993
47.

Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope.

Lucchese A, Stevanovic S, Sinha AA, Mittelman A, Kanduc D.

Peptides. 2003 Feb;24(2):193-7.

PMID:
12668202
48.

Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer.

Ashok BT, David L, Chen YG, Garikapaty VP, Chander B, Kanduc D, Mittelman A, Tiwari RK.

Int J Mol Med. 2003 Apr;11(4):465-71.

PMID:
12632099
49.

Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.

Ashok BT, Chen YG, Liu X, Garikapaty VP, Seplowitz R, Tschorn J, Roy K, Mittelman A, Tiwari RK.

Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S86-93.

PMID:
12570340
50.

Microarray analysis of diet-induced alterations in gene expression in the ACI rat prostate.

Reyes N, Iatropoulos M, Mittelman A, Geliebter J.

Eur J Cancer Prev. 2002 Aug;11 Suppl 2:S37-42.

PMID:
12570333

Supplemental Content

Loading ...
Support Center